11-47448165-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_005055.5(RAPSN):c.193-15C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,453,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
RAPSN
NM_005055.5 intron
NM_005055.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.360
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-47448165-G-T is Pathogenic according to our data. Variant chr11-47448165-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 8053.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=1}. Variant chr11-47448165-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAPSN | NM_005055.5 | c.193-15C>A | intron_variant | ENST00000298854.7 | NP_005046.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAPSN | ENST00000298854.7 | c.193-15C>A | intron_variant | 1 | NM_005055.5 | ENSP00000298854.2 | ||||
RAPSN | ENST00000352508.7 | c.193-15C>A | intron_variant | 1 | ENSP00000298853.3 | |||||
RAPSN | ENST00000529341.1 | c.193-15C>A | intron_variant | 1 | ENSP00000431732.1 | |||||
RAPSN | ENST00000524487.5 | c.193-15C>A | intron_variant | 5 | ENSP00000435551.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000415 AC: 1AN: 241002Hom.: 0 AF XY: 0.00000762 AC XY: 1AN XY: 131214
GnomAD3 exomes
AF:
AC:
1
AN:
241002
Hom.:
AF XY:
AC XY:
1
AN XY:
131214
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1453396Hom.: 0 Cov.: 36 AF XY: 0.00000138 AC XY: 1AN XY: 723176
GnomAD4 exome
AF:
AC:
1
AN:
1453396
Hom.:
Cov.:
36
AF XY:
AC XY:
1
AN XY:
723176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Congenital myasthenic syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 08, 2024 | Variant summary: RAPSN c.193-15C>A alters a non-conserved nucleotide located at a position not widely known to affect splicing. Several computational tools predict a significant impact on normal splicing: Two predict the variant weakens a 3' acceptor site. Three predict the variant creates a 3' acceptor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (Miller_2006). The variant allele was found at a frequency of 4.1e-06 in 241002 control chromosomes. c.193-15C>A has been reported in the literature in individuals affected with Congenital Myasthenic Syndrome (Krenn_2023, Miller_2006). These data indicate that the variant may be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 36308527, 16931511). ClinVar contains an entry for this variant (Variation ID: 8053). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Congenital myasthenic syndrome 11 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 10, 2006 | - - |
Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 02, 2021 | This sequence change falls in intron 1 of the RAPSN gene. It does not directly change the encoded amino acid sequence of the RAPSN protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with congenital myasthenic syndrome (PMID: 16931511). This variant is also known as IVS1-15C>A. ClinVar contains an entry for this variant (Variation ID: 8053). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 16931511). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
DS_AL_spliceai
Position offset: -15
Find out detailed SpliceAI scores and Pangolin per-transcript scores at